The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    PHOTOSTrapped along borders

  • 3

    Korea wins gold in League of Legends competition; Faker tops podium

  • 5

    VIDEOBustling Chuseok: Namsan Hanok Village immerses visitors in Korea's rich traditions

  • 7

    Pentagon's CWMD strategy document calls N. Korea 'persistent threat'

  • 9

    Builders vie for leadership in modular construction

  • 11

    Are 'finfluencers' helping or harming investment community?

  • 13

    Apple, China met to discuss Beijing's crackdown on western apps: WSJ

  • 15

    Poll shows 79% of young Koreans agree on need to improve ties with Japan

  • 17

    Second release of Fukushima wastewater to start next week

  • 19

    S. Korea eliminates N. Korea in women's table tennis doubles

  • 2

    BTS' Jungkook to drop 2nd solo single

  • 4

    Trailblazing nonagenarian artist honored for redefining Korean fiber art

  • 6

    Opposition leader Lee again proposes talks with President Yoon

  • 8

    BTS' Jungkook drops 2nd solo single

  • 10

    Yoon hosts Chuseok luncheon for Korean atomic bomb victims in Hiroshima

  • 12

    Korea fails to be included on FTSE Russell's global bond index

  • 14

    Swimmer Kim Woo-min captures 3rd gold in Hangzhou

  • 16

    INTERVIEW'Coexistence of different art hubs across Asia is necessary': Art Week Tokyo Director

  • 18

    S. Korea cruises past N. Korea in women's basketball

  • 20

    My left arm: how right-handed shooter won Asiad medal with left hand

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Opinion
  • Yun Byung-se
  • Kim Won-soo
  • Ahn Ho-young
  • Kim Sang-woo
  • Lee Kyung-hwa
  • Mitch Shin
  • Peter S. Kim
  • Daniel Shin
  • Jeon Su-mi
  • Jang Daul
  • Song Kyung-jin
  • Park Jung-won
  • Cho Hee-kyoung
  • Park Chong-hoon
  • Kim Sung-woo
  • Donald Kirk
  • John Burton
  • Robert D. Atkinson
  • Mark Peterson
  • Eugene Lee
  • Rushan Ziatdinov
  • Lee Jong-eun
  • Chyung Eun-ju and Joel Cho
  • Bernhard J. Seliger
  • Imran Khalid
  • Troy Stangarone
  • Jason Lim
  • Casey Lartigue, Jr.
  • Bernard Rowan
  • Steven L. Shields
  • Deauwand Myers
  • John J. Metzler
  • Andrew Hammond
  • Sandip Kumar Mishra
Sun, October 1, 2023 | 17:55
Park Jin
Korea, US should promote 'vaccine partnership'
Posted : 2020-12-23 16:27
Updated : 2021-04-22 15:42
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link

By Park Jin

The resurging coronavirus is wreaking havoc on a global scale. The U.S. records spiraling new infection cases exceeding 250,000 a day. The Republic of Korea had managed to keep the coronavirus eruption largely under control until recently. Due to the cold weather and perhaps slack containment however, the daily outbreaks of COVID-19 have been surpassing 1,000 since mid-December.

The resurgence of the COVID-19 pandemic has forced many countries to race for the acquisition of vaccines to prevent the unbridled spread of the potentially fatal disease. The Trump administration expedited the development of high-tech vaccines, spearheaded by leading companies such as Pfizer and Moderna. President-elect Joe Biden has already committed to ensuring that at least 100 million Americans get vaccine shots within 100 days of his inauguration.

South Korea possesses competitive production capabilities for high-tech vaccine manufacturing, but has conspicuously fallen behind in securing vaccines. The country should upgrade its scientific and technological cooperation with the U.S. to forge a mutually beneficial vaccine partnership.

The U.S. would do well to facilitate Korea's late access to the vaccine supply while the latter can provide efficient vaccine production to the former. This will strengthen the alliance through mutual support and more effective treatment and prevention efforts in times of common adversity.

Led by its "K-quarantine" model, South Korea's quarantine measures have been successful to date compared to efforts in the U.S., Europe and Japan. Factors that made this possible include the dedicated sacrifices of medical personnel, wearing masks at all times, strict maintenance of personal hygiene, social distancing, partial closing down of schools and restricting public gatherings in crowded places.

Along with its advanced medical and public health system, Korea has developed the polymerase chain reaction (PCR) industry and its "sampling-testing-disposal" technology through the influenza A and MERS crises.

As an article in the American Review of Public Administration explains, broad epidemiological investigation, a centralized political structure, ample public health budget and a flexible fiscal management system helped Korea deal with the epidemic crisis. The public confidence in the need for the government to take action is also pointed out as a success factor for K-quarantine.

Nevertheless, Korea is also faced with challenges. Despite the government's continued efforts by elevating the social distancing level to level 2.5, the third wave of the pandemic which began in November has resulted in higher risks as cases have multiplied tenfold in December.

There are also concerns about the potential limitations of K-quarantine. The first concern is regarding the restriction of human rights in the process.

Critics point out that individuals are constrained in terms of their civil and political freedoms and rights in the process of broad epidemiological investigations and the government's strong legal and administrative central control authority.

The second concern has to do with economic recession. Starting from Dec. 5, Seoul implemented more stringent regulations, closing down most stores after 9 p.m. Businesses that are sought out by a large segment of the population are facing hardship. The unemployment rate is rising as well.

Thirdly, Korean policy has been focused on regulatory quarantine efforts, rather than treatment and prevention. There are growing voices among medical experts calling for a paradigm shift from a quarantine-centered system toward a treatment and prevention-centered system through vaccines.

Compared to the U.S., Europe, and Japan, Korea's vaccination plan is still in its formative stages. The Korean government has signed a supply contract with the British company AstraZeneca to vaccinate 10 million people out of its 51.78 million population.

The government plan is to start acquiring new coronavirus vaccines in the first quarter of next year although it is reportedly known that the contract does not specify the supply date. Also the vaccine needs to be approved by the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) and/or the U.S. Food and Drug Administration (FDA).

Other than that, Korea is in the process of concluding purchase agreements with the COVAX Facility, Pfizer and Moderna for doses covering 10 million people each, and with Janssen for 4 million people. The exact timeframe for introducing these vaccines has not been confirmed yet.

In the early stage of COVID-19, Korea provided emergency support to the U.S. government's medical front-lines by sending 2 million face masks. Korea also shared its quarantine experience with the U.S. during the election season. Now, the two countries ought to move beyond information sharing and quarantine, toward pursuing a new objective involving treatment and prevention through the rapid development and distribution of vaccines.

Korean biopharmaceutical companies are evaluated to have the competitiveness needed to manufacture all types of vaccines currently under development throughout the world. Korea and the U.S. should agree on "vaccine swap" to help each other.

In the longer term, mass production of the vaccines developed in the U.S. will require not only domestic but also offshore production sites. Korea has the potential to become a strong partner with its advanced facilities and competitiveness meeting global standards.

In the short term, the U.S. should seriously consider supporting the timely supply of vaccines to Korea which urgently needs to secure the minimum necessary amount of authorized and safe vaccines. They will be distributed first to senior citizens, medical personnel, patients with chronic diseases, employees at infirmaries and welfare facilities, firefighters, police and military personnel before inoculating the whole population.

This will introduce the new "Korea-U.S. vaccine partnership" which will ensure the safety of the American as well as Korean people and enhance the spirit of the alliance.

Park Jin (parkjin916@naver.com) is a lawmaker of the opposition People Power Party. He chairs the party's special committee on diplomacy and security and previously served as president of the Korea-America Association.


 
miguel
wooribank
LG
Top 10 Stories
1[INTERVIEW] Risk-averse culture is forcing daring creators to flee showbiz INTERVIEWRisk-averse culture is forcing daring creators to flee showbiz
2Koreans adapt to soaring food prices Koreans adapt to soaring food prices
3[PHOTOS] Trapped along borders PHOTOSTrapped along borders
4Education ministry prohibits parents from recording classes Education ministry prohibits parents from recording classes
5[VIDEO] Bustling Chuseok: Namsan Hanok Village immerses visitors in Korea's rich traditions VIDEOBustling Chuseok: Namsan Hanok Village immerses visitors in Korea's rich traditions
6Builders vie for leadership in modular construction Builders vie for leadership in modular construction
7Value, consumer goods, financial stocks expected to gain momentum after Chuseok holiday Value, consumer goods, financial stocks expected to gain momentum after Chuseok holiday
8Are 'finfluencers' helping or harming investment community? Are 'finfluencers' helping or harming investment community?
9[INTERVIEW] ROK-US alliance is win-win partnership: KUSAF chief INTERVIEWROK-US alliance is win-win partnership: KUSAF chief
10Over 30,000 protesters march for climate actions Over 30,000 protesters march for climate actions
Top 5 Entertainment News
1[INTERVIEW] 'Coexistence of different art hubs across Asia is necessary': Art Week Tokyo Director INTERVIEW'Coexistence of different art hubs across Asia is necessary': Art Week Tokyo Director
2M+ deputy director discusses Seoul's potential to challenge Hong Kong as Asia's art hub M+ deputy director discusses Seoul's potential to challenge Hong Kong as Asia's art hub
3Trailblazing nonagenarian artist honored for redefining Korean fiber art Trailblazing nonagenarian artist honored for redefining Korean fiber art
4[INTERVIEW] With '30 Days,' Kang Ha-neul finds new level of comfort in acting INTERVIEWWith '30 Days,' Kang Ha-neul finds new level of comfort in acting
5Rwandan artists bring diversity to Seoul's art scene Rwandan artists bring diversity to Seoul's art scene
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group